Articles tagged "Vascular disease"

2015 American Transplant Congress
High Incidence of Masked Hypertension in Pediatric Recipients of Stem Cell Transplantation
A. Melk,¹ D. Thurn-Valsassina,¹ B. Schmidt,² R. Beier.³
¹Pediatric Nephrology, Hannover Medical School, Hannover, Germany; ²Nephrology, Hannover Medical School, Hannover, Germany; ³Pediatric Hematology, Hannover Medical School, Hannover, Germany.
Purpose: Different from recipients of a solid organ transplant, stem cell transplantation (SCT) recipients do not receive long term immunosuppressive treatment that may cause renal…
2015 American Transplant Congress
The Effects of Donor Specific Anti- Human Leukocyte Antigen Antibodies Late After Heart Transplantation
M. Kittleson, J. Patel, F. Liou, S. Siddiqui, A. Fong, M. Johnson, D. Chang, L. Czer, F. Esmailian, N. Reinsmoen, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: The development of anti-HLA antibodies following heart transplantation has been associated with poor outcomes, including lower survival and increased risk for the development of…
2015 American Transplant Congress
Longitudinal Follow-Up of Cardiovascular Comorbidity in Pediatric Renal Transplant Recipients – Results from the 4C-T Study
A. Melk,¹ D. Thurn-Valsassina,¹ B. Schmidt,¹ A. Duzova,² B. Soezeri,³ A. Bayazit,⁴ S. Caliskan,⁵ U. Querfeld,⁶ K. Ažukaitis,⁷ E. Wuehl,⁷ F. Schaefer.⁷
¹Hannover Medical School, Hannover, Germany; ²Hacettepe University Medical Faculty, Ankara, Turkey; ³Ege University Medical Faculty, Izmir, Turkey; ⁴Cukurova University, Faculty of Medicine, Adana, Turkey; ⁵Istanbul University Cerrahpasa Medial School, Istanbul, Turkey; ⁶Charité Universitätsmedizin Berlin, Berlin, Germany; ⁷Centre for Pediatric and Adolescent Medicine, Heidelberg, Germany.
Purpose: Children with chronic kidney disease (CKD) carry an increased cardiovascular risk. Cardiovascular death is the second leading cause of death in children after renal…
2015 American Transplant Congress
Inhibition of RhoA Pathway-Related Macrophage Functions Abrogates Chronic Rejection of Cardiac Allograft
M. Kloc, J. You, N. Tejpal, X. Li, R. Ghobrial.
TMHRI, Houston, TX.
Objective. Chronic rejection remains the main obstacle in the long-term success of organ transplantation. The long-term survival of allografted hearts is limited by a progressive…
2015 American Transplant Congress
Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System
A. Brar,¹ D. Stefanov,³ R. Jindal,² N. Sumrani,⁴ D. John,⁴ F. Tedla,¹ M. Salifu.¹
¹Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; ²Department of Surgery, Walter Reed National Military Medical Center, Uniformed Services University of Health Sciences, Bethesda, MD; ³Division of Research, SUNY Downstate School of Medicine, Brooklyn, NY; ⁴Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.
Introduction: There is lack of information whether waitlisted dialysis patients with peripheral vascular disease (PVD) benefit from kidney transplantation.Methods: We used a cohort of USRDS…
2015 American Transplant Congress
Conditioning of Mesenchymal Stromal Cells With mTOR Inhibitor Enhances Regenerative Properties of Secretome and Attenuates Vascular Calcification
B. Hegner,¹ C. Kurth,¹ T. Schaub,¹ C. Lange,² D. Dragun.¹
¹Clinic for Nephrology and Intensive Care Medicine, Charité University Hospital, Berlin, Germany; ²Department of Cell and Gene Therapy, University Medical Center Eppendorf, Hamburg, Germany.
Similar to patients with chronic kidney disease, recipients of kidney transplants are a high-risk population for cardiovascular events due to arterial media calcification in particular…